市場調査レポート：世界の代謝遺伝子検査市場（～2028年）：次世代シーケンサー、マルチプレックス・ライゲーション依存性プローブ増幅、羊水検査、その他

• 英文タイトル：Global Metabolic Genetic Testing Market Insights, Forecast to 2028

Global Metabolic Genetic Testing Market Insights, Forecast to 2028「世界の代謝遺伝子検査市場（～2028年）：次世代シーケンサー、マルチプレックス・ライゲーション依存性プローブ増幅、羊水検査、その他」（市場規模、市場予測）調査レポートです。

• レポートコード：MRC2Q12-17891
• 出版社/出版日：QYResearch / 2022年12月
• レポート形態：英文、PDF、90ページ
• 納品方法：Eメール（納期：3営業日）
• 産業分類：医療機器＆消耗品

• 販売価格（消費税別）

Single User	￥735,000 (USD4,900)	▷ お問い合わせ
Enterprise License	￥1,470,000 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

新型コロナウイルス感染症とロシア・ウクライナ戦争の影響により、代謝遺伝子検査のグローバル市場は 2022にxxxドルと推定され、2028年までにxxxドルの規模に達し、2022年から2028年の予測期間中にxxx%のCAGRで成長すると予測されています。
代謝遺伝子検査のアメリカ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。
代謝遺伝子検査の中国市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。
代謝遺伝子検査のヨーロッパ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。

生産面において、本レポートは2017年から2022年までの代謝遺伝子検査の生産、成長率、メーカー別市場シェア、地域別市場シェア、および2028年までの予測を調査しています。販売面において、本レポートは2017年から2022年までの地域別、企業別、タイプ別、アプリケーション別の代謝遺伝子検査の売上および2028年までの予測に焦点を当てています。

代謝遺伝子検査のグローバル主要企業には、Centogene N.V、MedGenome、Blueprint Genetics Oy、Invitae Corporation、Quest Diagnostics、Orig3n、Bionano Genomics、Devyserなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。

代謝遺伝子検査市場は、タイプとアプリケーションによって区分されます。世界の代謝遺伝子検査市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別およびアプリケーション別の販売量、売上、予測に焦点を当てています。

【タイプ別セグメント】
次世代シーケンサー、マルチプレックス・ライゲーション依存性プローブ増幅、羊水検査、その他

【アプリケーション別セグメント】
病院、専門クリニック、診断所、その他

【掲載地域】
北米：アメリカ、カナダ
ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米：メキシコ、ブラジル、アルゼンチン
中東・アフリカ：トルコ、サウジアラビア、UAE

【目次（一部）】

・調査の範囲
- 代謝遺伝子検査製品概要
- タイプ別市場（次世代シーケンサー、マルチプレックス・ライゲーション依存性プローブ増幅、羊水検査、その他）
- アプリケーション別市場（病院、専門クリニック、診断所、その他）
- 調査の目的
・エグゼクティブサマリー
- 世界の代謝遺伝子検査販売量予測2017-2028
- 世界の代謝遺伝子検査売上予測2017-2028
- 代謝遺伝子検査の地域別販売量
- 代謝遺伝子検査の地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別代謝遺伝子検査販売量
- 主要メーカー別代謝遺伝子検査売上
- 主要メーカー別代謝遺伝子検査価格
- 競争状況の分析
- 企業M&A動向
・タイプ別市場規模（次世代シーケンサー、マルチプレックス・ライゲーション依存性プローブ増幅、羊水検査、その他）
- 代謝遺伝子検査のタイプ別販売量
- 代謝遺伝子検査のタイプ別売上
- 代謝遺伝子検査のタイプ別価格
・アプリケーション別市場規模（病院、専門クリニック、診断所、その他）
- 代謝遺伝子検査のアプリケーション別販売量
- 代謝遺伝子検査のアプリケーション別売上
- 代謝遺伝子検査のアプリケーション別価格
・北米市場
- 北米の代謝遺伝子検査市場規模（タイプ別、アプリケーション別）
- 主要国別の代謝遺伝子検査市場規模（アメリカ、カナダ）
・ヨーロッパ市場
- ヨーロッパの代謝遺伝子検査市場規模（タイプ別、アプリケーション別）
- 主要国別の代謝遺伝子検査市場規模（ドイツ、フランス、イギリス、イタリア、ロシア）
・アジア太平洋市場
- アジア太平洋の代謝遺伝子検査市場規模（タイプ別、アプリケーション別）
- 主要国別の代謝遺伝子検査市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア）
・中南米市場
- 中南米の代謝遺伝子検査市場規模（タイプ別、アプリケーション別）
- 主要国別の代謝遺伝子検査市場規模（メキシコ、ブラジル、アルゼンチン）
・中東・アフリカ市場
- 中東・アフリカの代謝遺伝子検査市場規模（タイプ別、アプリケーション別）
- 主要国別の代謝遺伝子検査市場規模（トルコ、サウジアラビア）
・企業情報
Centogene N.V、MedGenome、Blueprint Genetics Oy、Invitae Corporation、Quest Diagnostics、Orig3n、Bionano Genomics、Devyser
・産業チェーン及び販売チャネル分析
- 代謝遺伝子検査の産業チェーン分析
- 代謝遺伝子検査の原材料
- 代謝遺伝子検査の生産プロセス
- 代謝遺伝子検査の販売及びマーケティング
- 代謝遺伝子検査の主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- 代謝遺伝子検査の産業動向
- 代謝遺伝子検査のマーケットドライバー
- 代謝遺伝子検査の課題
- 代謝遺伝子検査の阻害要因
・主な調査結果

Metabolic genetic disorders are caused due to either absence of any gene or presence of inactive gene leading to enzyme deficiency.The Metabolic Genetic Testing market is majorly driven by advancements in DNA sequencing techniques. These testing method provides an accurate course of treatment and specific investigations.
Market Analysis and Insights: Global Metabolic Genetic Testing Market
The global Metabolic Genetic Testing market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, Next Generation Sequencing accounting for % of the Metabolic Genetic Testing global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospitals segment is altered to an % CAGR throughout this forecast period.
China Metabolic Genetic Testing market size is valued at US$ million in 2021, while the North America and Europe Metabolic Genetic Testing are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Metabolic Genetic Testing landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Metabolic Genetic Testing market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Metabolic Genetic Testing market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Metabolic Genetic Testing market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Metabolic Genetic Testing market.
Global Metabolic Genetic Testing Scope and Market Size
Metabolic Genetic Testing market is segmented by players, region (country), by Technology and by Application. Players, stakeholders, and other participants in the global Metabolic Genetic Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Technology and by Application for the period 2017-2028.
Segment by Technology
Next Generation Sequencing
Multiplex Ligation-Dependent Probe Amplification
Amniocentesis
Others
Segment by Application
Hospitals
Specialty Clinics
Diagnostics Laboratories
Others
By Company
Centogene N.V
MedGenome
Blueprint Genetics Oy
Invitae Corporation
Quest Diagnostics
Orig3n
Bionano Genomics
Devyser
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

レポート目次

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Technology
1.2.1 Global Metabolic Genetic Testing Market Size Growth Rate by Technology, 2017 VS 2021 VS 2028
1.2.2 Next Generation Sequencing
1.2.3 Multiplex Ligation-Dependent Probe Amplification
1.2.4 Amniocentesis
1.2.5 Others
1.3 Market by Application
1.3.1 Global Metabolic Genetic Testing Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Specialty Clinics
1.3.4 Diagnostics Laboratories
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Metabolic Genetic Testing Market Perspective (2017-2028)
2.2 Metabolic Genetic Testing Growth Trends by Region
2.2.1 Metabolic Genetic Testing Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Metabolic Genetic Testing Historic Market Size by Region (2017-2022)
2.2.3 Metabolic Genetic Testing Forecasted Market Size by Region (2023-2028)
2.3 Metabolic Genetic Testing Market Dynamics
2.3.1 Metabolic Genetic Testing Industry Trends
2.3.2 Metabolic Genetic Testing Market Drivers
2.3.3 Metabolic Genetic Testing Market Challenges
2.3.4 Metabolic Genetic Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Metabolic Genetic Testing Players by Revenue
3.1.1 Global Top Metabolic Genetic Testing Players by Revenue (2017-2022)
3.1.2 Global Metabolic Genetic Testing Revenue Market Share by Players (2017-2022)
3.2 Global Metabolic Genetic Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Metabolic Genetic Testing Revenue
3.4 Global Metabolic Genetic Testing Market Concentration Ratio
3.4.1 Global Metabolic Genetic Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Metabolic Genetic Testing Revenue in 2021
3.5 Metabolic Genetic Testing Key Players Head office and Area Served
3.6 Key Players Metabolic Genetic Testing Product Solution and Service
3.7 Date of Enter into Metabolic Genetic Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Metabolic Genetic Testing Breakdown Data by Technology
4.1 Global Metabolic Genetic Testing Historic Market Size by Technology (2017-2022)
4.2 Global Metabolic Genetic Testing Forecasted Market Size by Technology (2023-2028)
5 Metabolic Genetic Testing Breakdown Data by Application
5.1 Global Metabolic Genetic Testing Historic Market Size by Application (2017-2022)
5.2 Global Metabolic Genetic Testing Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Metabolic Genetic Testing Market Size (2017-2028)
6.2 North America Metabolic Genetic Testing Market Size by Technology
6.2.1 North America Metabolic Genetic Testing Market Size by Technology (2017-2022)
6.2.2 North America Metabolic Genetic Testing Market Size by Technology (2023-2028)
6.2.3 North America Metabolic Genetic Testing Market Share by Technology (2017-2028)
6.3 North America Metabolic Genetic Testing Market Size by Application
6.3.1 North America Metabolic Genetic Testing Market Size by Application (2017-2022)
6.3.2 North America Metabolic Genetic Testing Market Size by Application (2023-2028)
6.3.3 North America Metabolic Genetic Testing Market Share by Application (2017-2028)
6.4 North America Metabolic Genetic Testing Market Size by Country
6.4.1 North America Metabolic Genetic Testing Market Size by Country (2017-2022)
6.4.2 North America Metabolic Genetic Testing Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Metabolic Genetic Testing Market Size (2017-2028)
7.2 Europe Metabolic Genetic Testing Market Size by Technology
7.2.1 Europe Metabolic Genetic Testing Market Size by Technology (2017-2022)
7.2.2 Europe Metabolic Genetic Testing Market Size by Technology (2023-2028)
7.2.3 Europe Metabolic Genetic Testing Market Share by Technology (2017-2028)
7.3 Europe Metabolic Genetic Testing Market Size by Application
7.3.1 Europe Metabolic Genetic Testing Market Size by Application (2017-2022)
7.3.2 Europe Metabolic Genetic Testing Market Size by Application (2023-2028)
7.3.3 Europe Metabolic Genetic Testing Market Share by Application (2017-2028)
7.4 Europe Metabolic Genetic Testing Market Size by Country
7.4.1 Europe Metabolic Genetic Testing Market Size by Country (2017-2022)
7.4.2 Europe Metabolic Genetic Testing Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Metabolic Genetic Testing Market Size (2017-2028)
8.2 Asia-Pacific Metabolic Genetic Testing Market Size by Technology
8.2.1 Asia-Pacific Metabolic Genetic Testing Market Size by Technology (2017-2022)
8.2.2 Asia-Pacific Metabolic Genetic Testing Market Size by Technology (2023-2028)
8.2.3 Asia-Pacific Metabolic Genetic Testing Market Share by Technology (2017-2028)
8.3 Asia-Pacific Metabolic Genetic Testing Market Size by Application
8.3.1 Asia-Pacific Metabolic Genetic Testing Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Metabolic Genetic Testing Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Metabolic Genetic Testing Market Share by Application (2017-2028)
8.4 Asia-Pacific Metabolic Genetic Testing Market Size by Region
8.4.1 Asia-Pacific Metabolic Genetic Testing Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Metabolic Genetic Testing Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Metabolic Genetic Testing Market Size (2017-2028)
9.2 Latin America Metabolic Genetic Testing Market Size by Technology
9.2.1 Latin America Metabolic Genetic Testing Market Size by Technology (2017-2022)
9.2.2 Latin America Metabolic Genetic Testing Market Size by Technology (2023-2028)
9.2.3 Latin America Metabolic Genetic Testing Market Share by Technology (2017-2028)
9.3 Latin America Metabolic Genetic Testing Market Size by Application
9.3.1 Latin America Metabolic Genetic Testing Market Size by Application (2017-2022)
9.3.2 Latin America Metabolic Genetic Testing Market Size by Application (2023-2028)
9.3.3 Latin America Metabolic Genetic Testing Market Share by Application (2017-2028)
9.4 Latin America Metabolic Genetic Testing Market Size by Country
9.4.1 Latin America Metabolic Genetic Testing Market Size by Country (2017-2022)
9.4.2 Latin America Metabolic Genetic Testing Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Metabolic Genetic Testing Market Size (2017-2028)
10.2 Middle East & Africa Metabolic Genetic Testing Market Size by Technology
10.2.1 Middle East & Africa Metabolic Genetic Testing Market Size by Technology (2017-2022)
10.2.2 Middle East & Africa Metabolic Genetic Testing Market Size by Technology (2023-2028)
10.2.3 Middle East & Africa Metabolic Genetic Testing Market Share by Technology (2017-2028)
10.3 Middle East & Africa Metabolic Genetic Testing Market Size by Application
10.3.1 Middle East & Africa Metabolic Genetic Testing Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Metabolic Genetic Testing Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Metabolic Genetic Testing Market Share by Application (2017-2028)
10.4 Middle East & Africa Metabolic Genetic Testing Market Size by Country
10.4.1 Middle East & Africa Metabolic Genetic Testing Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Metabolic Genetic Testing Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Centogene N.V
11.1.1 Centogene N.V Company Details
11.1.2 Centogene N.V Business Overview
11.1.3 Centogene N.V Metabolic Genetic Testing Introduction
11.1.4 Centogene N.V Revenue in Metabolic Genetic Testing Business (2017-2022)
11.1.5 Centogene N.V Recent Developments
11.2 MedGenome
11.2.1 MedGenome Company Details
11.2.2 MedGenome Business Overview
11.2.3 MedGenome Metabolic Genetic Testing Introduction
11.2.4 MedGenome Revenue in Metabolic Genetic Testing Business (2017-2022)
11.2.5 MedGenome Recent Developments
11.3 Blueprint Genetics Oy
11.3.1 Blueprint Genetics Oy Company Details
11.3.2 Blueprint Genetics Oy Business Overview
11.3.3 Blueprint Genetics Oy Metabolic Genetic Testing Introduction
11.3.4 Blueprint Genetics Oy Revenue in Metabolic Genetic Testing Business (2017-2022)
11.3.5 Blueprint Genetics Oy Recent Developments
11.4 Invitae Corporation
11.4.1 Invitae Corporation Company Details
11.4.2 Invitae Corporation Business Overview
11.4.3 Invitae Corporation Metabolic Genetic Testing Introduction
11.4.4 Invitae Corporation Revenue in Metabolic Genetic Testing Business (2017-2022)
11.4.5 Invitae Corporation Recent Developments
11.5 Quest Diagnostics
11.5.1 Quest Diagnostics Company Details
11.5.2 Quest Diagnostics Business Overview
11.5.3 Quest Diagnostics Metabolic Genetic Testing Introduction
11.5.4 Quest Diagnostics Revenue in Metabolic Genetic Testing Business (2017-2022)
11.5.5 Quest Diagnostics Recent Developments
11.6 Orig3n
11.6.1 Orig3n Company Details
11.6.2 Orig3n Business Overview
11.6.3 Orig3n Metabolic Genetic Testing Introduction
11.6.4 Orig3n Revenue in Metabolic Genetic Testing Business (2017-2022)
11.6.5 Orig3n Recent Developments
11.7 Bionano Genomics
11.7.1 Bionano Genomics Company Details
11.7.2 Bionano Genomics Business Overview
11.7.3 Bionano Genomics Metabolic Genetic Testing Introduction
11.7.4 Bionano Genomics Revenue in Metabolic Genetic Testing Business (2017-2022)
11.7.5 Bionano Genomics Recent Developments
11.8 Devyser
11.8.1 Devyser Company Details
11.8.2 Devyser Business Overview
11.8.3 Devyser Metabolic Genetic Testing Introduction
11.8.4 Devyser Revenue in Metabolic Genetic Testing Business (2017-2022)
11.8.5 Devyser Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer